Bright Minds Biosciences Inc. (DRUG)
NASDAQ: DRUG · Real-Time Price · USD
19.32
-2.23 (-10.35%)
Nov 4, 2026, 11:17 AM EST - Market open
Bright Minds Biosciences Employees
Bright Minds Biosciences had 26 employees as of September 30, 2025. The number of employees increased by 25 or 2,500.00% compared to the previous year.
Employees
26
Change (1Y)
25
Growth (1Y)
2,500.00%
Revenue / Employee
n/a
Profits / Employee
-$663,789
Market Cap
233.80M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2025 | 26 | 25 | 2,500.00% |
| Sep 30, 2024 | 1 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| MiMedx Group | 808 |
| Valneva SE | 620 |
| Geron | 258 |
| Arvinas | 246 |
| Puma Biotechnology | 179 |
| Neurogene | 131 |
| Crescent Biopharma | 69 |
| CytomX Therapeutics | 69 |
DRUG News
- 20 hours ago - DRUG SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Bright Minds Biosciences - PRNewsWire
- 1 day ago - Bright Minds price target lowered to $107 from $126 at Baird - TheFly
- 1 day ago - Bright Minds Biosciences Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Bright Minds Biosciences (DRUG) - PRNewsWire
- 1 day ago - Bright Minds price target lowered to $37 from $147 at BTIG - TheFly
- 1 day ago - Why Did Bright Minds Biosciences Stock (DRUG) Plummet 55% Today? - TipRanks
- 2 days ago - Bright Minds BMB-101 partial hold clouds U.S. DEE timeline, says H.C. Wainwright - TheFly
- 2 days ago - FDA places clinical hold on Bright Minds BMB-101-105 IND application - TheFly
- 2 days ago - Bright Minds Biosciences Provides Update About Planned Study with BMB-101 in Developmental and Epileptic Encephalopathies - GlobeNewsWire